Arrowhead Pharmaceuticals (ARWR) shares with a strong 20% move higher last week though still down 30% YTD and worked out of a multi-month downtrend after holding key support from March. ARWR on 10/19 saw an unusual buy of 2000 March $30 calls for $2....
